Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mio Nukiwa"'
Autor:
Masakazu Koiwa, Nobuo Ida, Yoichiro Koshi, Reiji Nishio, Yoshinori Kakizawa, Mio Nukiwa, Taisuke Hirano, Michizoe Junji
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 142(1)
A novel formulation of biodegradable microparticles was developed for the sustained release of peptide and protein drugs. The microparticles were formed by the aggregation of protein nanoparticles through water-in-oil (W/O) emulsion-lyophilization an
Autor:
Takuji Suzuki, Jamal Zaini, Mio Nukiwa, S. Andarini, Takao Hayakawa, Toshiaki Kikuchi, Tatsuro Fukuhara, Masahiko Kanehira, Hong Xin, Toshihiro Nukiwa, Yasuo Saijo, Hiroyuki Mizuguchi
Publikováno v:
European journal of immunology. 36(4)
Fractalkine (CX3CL1) is a unique membrane-bound CX3C chemokine that serves as a potent chemoattractant for lymphocytes. The hypothesis of this study is that dendritic cells (DC) genetically modified ex vivo to overexpress fractalkine would enhance th
Autor:
Prasenohadi Pradono, Toshihiro Nukiwa, Kazuo Sugamura, Takuji Suzuki, Makoto Maemondo, Toshiaki Kikuchi, Akira Inoue, Naoto Ishii, Mio Nukiwa, S. Andarini, Yasuo Saijo, Shinya Ohkouchi
Publikováno v:
Cancer research. 64(9)
OX40 ligand (OX40L), the ligand for OX40 on activated CD4+ T cells, has adjuvant properties for establishing effective T-cell immunity, a potent effector arm of the immune system against cancer. The hypothesis of this study is that in vivo genetic en